Who will benefit from globally promoted pneumonia vaccine?
the pneumonia vaccine that the Global Alliance for Vaccines and Immunization, a public-private coalition, and who are promoting in developing countries is expensive, inefficient and causes serious side-effects, contends a letter published in a public health journal.
In a letter to the Bulletin of the World Health Organization published online, paediatricians Jacob Puliyel and Sona Chowdhary of St. Stephen
Technology Partners: MimirTech
Links:
[1] http://admin.indiaenvironmentportal.org.in/news/wrong-cure
[2] http://admin.indiaenvironmentportal.org.in/category/author/sumana-narayanan
[3] http://admin.indiaenvironmentportal.org.in/category/newspaper/down-earth
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health-effects
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/asthma
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/medical-research
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/vaccination
[10] http://admin.indiaenvironmentportal.org.in/category/thesaurus/child-health
[11] http://admin.indiaenvironmentportal.org.in/category/thesaurus/pneumonia
[12] http://admin.indiaenvironmentportal.org.in/category/thesaurus/who
[13] http://admin.indiaenvironmentportal.org.in/category/thesaurus/india
[14] http://admin.indiaenvironmentportal.org.in/category/thesaurus/developing-countries
